The rheumatology team ordered several tests, including antinuclear antibody (ANA) testing by indirect immunofluorescence assay (IFA), a comprehensive myositis-specific antibody panel (myocyte panel 11 antibodies), and a 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) antibody test. The gene discussed is HMGCR; the disease is myositis disease.